[A case of fulminant hepatitis developing in a HBsAG carrier after chemotherapy of malignant lymphoma].
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002353:Carrier State / Q000276:immunology*; D005260:Female; D006509:Hepatitis B / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D006514:Hepatitis B Surface Antigens